Phalangeal microgeodic syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:352636M89.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Phalangeal microgeodic syndrome is a very rare bone condition that mainly affects the small bones of the fingers (phalanges). The term 'microgeodic' refers to tiny cyst-like holes or cavities that form within the bone, which can be seen on X-rays. This condition primarily affects children, most commonly between the ages of 3 and 12 years old. It tends to occur during the cold winter months and is thought to be related to cold exposure and poor blood circulation in the fingers. Children with this condition typically develop painful swelling in one or more fingers. The affected fingers may appear red, swollen, and tender. X-rays show characteristic small round or oval areas of bone loss (microgeodic changes) within the finger bones. In some cases, the fingers may become stiff or difficult to move. The good news is that phalangeal microgeodic syndrome is generally a self-limiting condition, meaning it tends to get better on its own over time. Treatment is mainly supportive and focuses on managing pain, keeping the hands warm, and protecting the fingers from further cold exposure. Most children recover fully without lasting damage to their bones, though the condition can sometimes recur during subsequent winters. The exact cause is not fully understood, but it is believed to involve a combination of cold-induced blood vessel spasm and local bone changes rather than a genetic mutation.

Also known as:

Key symptoms:

Painful swelling of one or more fingersRedness of affected fingersTenderness when touching the fingersStiffness in the finger jointsDifficulty bending or straightening the fingersSwelling that worsens in cold weatherSkin color changes in the fingers during cold exposureMild warmth over the swollen areaDecreased grip strength in the affected handOccasional involvement of toes

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Phalangeal microgeodic syndrome.

View clinical trials →

No actively recruiting trials found for Phalangeal microgeodic syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Phalangeal microgeodic syndrome community →

No specialists are currently listed for Phalangeal microgeodic syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Phalangeal microgeodic syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Phalangeal microgeodic syndromeForum →

No community posts yet. Be the first to share your experience with Phalangeal microgeodic syndrome.

Start the conversation →

Latest news about Phalangeal microgeodic syndrome

No recent news articles for Phalangeal microgeodic syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How long will it take for my child's symptoms to improve?,Are there any medications that can help with the pain and swelling?,What can we do to prevent this from happening again next winter?,Will this condition cause any permanent damage to my child's fingers or bones?,Should my child avoid any specific activities while the fingers are swollen?,How often should we come back for follow-up X-rays?,Is there anything else this could be, and do we need additional tests to rule out other conditions?

Common questions about Phalangeal microgeodic syndrome

What is Phalangeal microgeodic syndrome?

Phalangeal microgeodic syndrome is a very rare bone condition that mainly affects the small bones of the fingers (phalanges). The term 'microgeodic' refers to tiny cyst-like holes or cavities that form within the bone, which can be seen on X-rays. This condition primarily affects children, most commonly between the ages of 3 and 12 years old. It tends to occur during the cold winter months and is thought to be related to cold exposure and poor blood circulation in the fingers. Children with this condition typically develop painful swelling in one or more fingers. The affected fingers may appe

How is Phalangeal microgeodic syndrome inherited?

Phalangeal microgeodic syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Phalangeal microgeodic syndrome typically begin?

Typical onset of Phalangeal microgeodic syndrome is childhood. Age of onset can vary across affected individuals.